Company file
keyboard_backspaceBack to directoryIdentity
Sangamo Therapeutics France
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. Sangamo Therapeutics France is the French subsidiary of Sangamo Therapeutics. Its actitivies are focused on ex vivo gene-edited cell therapy for the treatment of inflammatory and autoimmune diseases.
N/A
Contact
Allée de la Nertière - Les Cardoulines Bat HT1
06560 VALBONNE
France
0497212727
Activities
- Research structure
- Analytical Process, Quality assement, Quality Control
- Cleaning
- CGMP
- Quality control
- CMC
- CMC
- Targer Identification
- Targer Identification
- Gene modification
- Gene modification
- Gene Delivery system
- Lentivirus
- Adeno-Associated Virus (AAV)
- scFv Generation
- Mouse immunisation
- CAR Construction
- Intracellular Domain
- T-cell activation/transduction
- Bioproduction
- Bioproduction
- Ex Vivo & In Vivo Strategy
- Ex Vivo & In Vivo Strategy
- Cell modification
- Gene modifcation
- Formulation
- Formulation
